PURPOSE: To evaluate the suitability of including both Heidelberg Retina Tomograph-I (HRT-I) and HRT-II examinations in the same longitudinal series for HRT topographic change analysis (TCA) and to evaluate parabolic error correction (PEC) to improve the agreement between HRT-I and HRT-II examinations. METHODS: A total of 66 eyes from the University of California San Diego Diagnostic Innovations in Glaucoma Study with baseline HRT-I and HRT-II examinations obtained on the same day and ≥ 3 HRT-II follow-up examinations were included. Two TCA analyses, HRT-I examination at baseline (HRT-I-mixed series) and HRT-II examination at baseline (HRT-II-only series) were compared. Agreement between the HRT-I-mixed and HRT-II-only series were estimated using Bland-Altman plots. Agreement was assessed: (1) using the current HRT software settings (PEC applied only to HRT-II-only series), and (2) modified HRT settings (PEC also applied to HRT-I-mixed series). RESULTS: With current HRT software settings, the HRT-I-mixed series significantly overestimated change locations (ie, red pixels) compared with the HRT-II-only series as indicated by statistically significant proportional biases in the Bland-Altman analysis. By applying PEC to HRT-I-mixed series there were no statistically significant biases in the TCA parameter estimates compared with the HRT-II-only series. CONCLUSION: In some eyes, HRT-I and HRT-II baseline examinations are not interchangeable in TCA analysis without parabolic error correction. HRT-I-mixed series detected more changes characteristic of glaucoma when there were only minimal changes in the HRT-II-only series. Our results suggest that in the majority of cases, with PEC, HRT-I examinations may be included in a longitudinal series containing HRT-II examinations.
PURPOSE: To evaluate the suitability of including both Heidelberg Retina Tomograph-I (HRT-I) and HRT-II examinations in the same longitudinal series for HRT topographic change analysis (TCA) and to evaluate parabolic error correction (PEC) to improve the agreement between HRT-I and HRT-II examinations. METHODS: A total of 66 eyes from the University of California San Diego Diagnostic Innovations in Glaucoma Study with baseline HRT-I and HRT-II examinations obtained on the same day and ≥ 3 HRT-II follow-up examinations were included. Two TCA analyses, HRT-I examination at baseline (HRT-I-mixed series) and HRT-II examination at baseline (HRT-II-only series) were compared. Agreement between the HRT-I-mixed and HRT-II-only series were estimated using Bland-Altman plots. Agreement was assessed: (1) using the current HRT software settings (PEC applied only to HRT-II-only series), and (2) modified HRT settings (PEC also applied to HRT-I-mixed series). RESULTS: With current HRT software settings, the HRT-I-mixed series significantly overestimated change locations (ie, red pixels) compared with the HRT-II-only series as indicated by statistically significant proportional biases in the Bland-Altman analysis. By applying PEC to HRT-I-mixed series there were no statistically significant biases in the TCA parameter estimates compared with the HRT-II-only series. CONCLUSION: In some eyes, HRT-I and HRT-II baseline examinations are not interchangeable in TCA analysis without parabolic error correction. HRT-I-mixed series detected more changes characteristic of glaucoma when there were only minimal changes in the HRT-II-only series. Our results suggest that in the majority of cases, with PEC, HRT-I examinations may be included in a longitudinal series containing HRT-II examinations.
Authors: D F Garway-Heath; D Poinoosawmy; G Wollstein; A Viswanathan; D Kamal; L Fontana; R A Hitchings Journal: Br J Ophthalmol Date: 1999-06 Impact factor: 4.638
Authors: Andrew J Patterson; David F Garway-Heath; Nicholas G Strouthidis; David P Crabb Journal: Invest Ophthalmol Vis Sci Date: 2005-05 Impact factor: 4.799
Authors: Dimitrios Kourkoutas; Yvonne M Buys; John G Flanagan; Wendy V Hatch; Carmen Balian; Graham E Trope Journal: Can J Ophthalmol Date: 2007-02 Impact factor: 1.882
Authors: D Kourkoutas; Y M Buys; J G Flanagan; N Karamaounas; G Georgopoulos; E Iliakis; M M Moschos; G E Trope Journal: J Ophthalmol Date: 2014-01-21 Impact factor: 1.909
Authors: Ya Xing Wang; Neil O'Leary; Nicholas G Strouthidis; Edward T White; Tuan A Ho; David F Garway-Heath Journal: J Glaucoma Date: 2013 Oct-Nov Impact factor: 2.503